Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 28, 2020
Anne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
JCO Precision Oncology
|
February 17, 2022
Trametinib-Induced Remission of an <i>MEK1</i>-Mutated Langerhans Cell Histiocytosis
Matina Papapanagiotou, Klaus G Griewank, Uwe Hillen, et al.
Frontiers in Oncology
|
August 30, 2021
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
Jan-Malte Placke, Josefine Rawitzer, Henning Reis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis
Eleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.
Nature Reviews. Disease Primers
|
May 19, 2016
Melanoma
Dirk Schadendorf, David E Fisher, Claus Garbe, et al.
The Journal of Investigative Dermatology
|
June 24, 2019
Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells
Felix C E Vogel, Natalie Bordag, Elmar Zügner, et al.
Cancers
|
February 13, 2021
Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma
Renáta Váraljai, Susanne Horn, Antje Sucker, et al.
Cell Communication and Signaling : CCS
|
March 5, 2026
The role of KDM5B in creating synthetic vulnerabilities in combination with radiotherapy in melanoma cells
Safa Larafa, Merle Schaffrin, Peer Braß, et al.
Oncotarget
|
April 6, 2017
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
Ioana Cosgarea, Selma Ugurel, Antje Sucker, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 28, 2020
Anne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
JCO Precision Oncology
|
February 17, 2022
Trametinib-Induced Remission of an <i>MEK1</i>-Mutated Langerhans Cell Histiocytosis
Matina Papapanagiotou, Klaus G Griewank, Uwe Hillen, et al.
Frontiers in Oncology
|
August 30, 2021
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
Jan-Malte Placke, Josefine Rawitzer, Henning Reis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis
Eleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.
Nature Reviews. Disease Primers
|
May 19, 2016
Melanoma
Dirk Schadendorf, David E Fisher, Claus Garbe, et al.
The Journal of Investigative Dermatology
|
June 24, 2019
Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells
Felix C E Vogel, Natalie Bordag, Elmar Zügner, et al.
Cancers
|
February 13, 2021
Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma
Renáta Váraljai, Susanne Horn, Antje Sucker, et al.
Cell Communication and Signaling : CCS
|
March 5, 2026
The role of KDM5B in creating synthetic vulnerabilities in combination with radiotherapy in melanoma cells
Safa Larafa, Merle Schaffrin, Peer Braß, et al.
Oncotarget
|
April 6, 2017
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
Ioana Cosgarea, Selma Ugurel, Antje Sucker, et al.
Page
of 11